Rogers publishes Q2 2026 MD&A for three and six months ended June 30, 2026
RCI•Q2 2026 results and MLSE acquisition plans
Rogers released its Q2 2026 MD&A, highlighting plans to buy the remaining 25% of MLSE for CAD 4.35 billion, expected in Q4.
- Net loss of CAD 665 million driven by a CAD 1.03 billion non-cash loss on revaluation of the MLSE put liability.
- Revenue rose 8% to CAD 5.62 billion; adjusted EBITDA increased 3% to CAD 2.44 billion; adjusted EBITDA margin fell to 43.5% from 45.3%.
- Free cash flow increased 6% to CAD 982 million; capital expenditures fell 16% to CAD 695 million; available liquidity totaled CAD 6.1 billion.
- Debt leverage ratio improved to 3.8 from 4.0; dividend of CAD 0.5 per share declared.
